Sanj Patel, CEO & Chairman of the Board, stated that "Year-to-date, in 2025, we've continued to execute and meaningfully advance our commercial business and clinical development portfolio." He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results